Comment on the work The place of Exemestane in the treatment of metastatic breast cancer in postmenopausal patients

被引：0
|
作者：
Krzakowski, Maciej [1 ]
机构：
[1] Ctr Onkol Inst Im Marii Sklodowskiej Curie, Klin Nowotworow Pluca & Klatki Piersiowej, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：252 / 254
页数：3
相关论文
共 50 条
  • [21] Exemestane in postmenopausal patients with advanced breast cancer: A dose-finding study
    Zilembo, N
    Noberasco, C
    Martinetti, A
    Mariani, L
    Rimassa, L
    DelVecchio, M
    Laffranchi, A
    Orefice, S
    Galante, E
    Sguotti, C
    Bajetta, E
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 963 - 963
  • [22] Exemestane for primary prevention of breast cancer in postmenopausal women
    Zhang, Yang
    Simondsen, Katherine
    Kolesar, Jill M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (16) : 1384 - 1388
  • [23] Effects of exemestane and tamoxifen in a postmenopausal breast cancer model
    Jelovac, D
    Macedo, L
    Handratta, V
    Long, BJ
    Goloubeva, OG
    Ingle, JN
    Brodie, AMH
    CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7375 - 7381
  • [24] Exemestane for Breast-Cancer Prevention in Postmenopausal Women
    Goss, Paul E.
    Ingle, James N.
    Ales-Martinez, Jose E.
    Cheung, Angela M.
    Chlebowski, Rowan T.
    Wactawski-Wende, Jean
    McTiernan, Anne
    Robbins, John
    Johnson, Karen C.
    Martin, Lisa W.
    Winquist, Eric
    Sarto, Gloria E.
    Garber, Judy E.
    Fabian, Carol J.
    Pujol, Pascal
    Maunsell, Elizabeth
    Farmer, Patricia
    Gelmon, Karen A.
    Tu, Dongsheng
    Richardson, Harriet
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25): : 2381 - 2391
  • [25] EXEMESTANE PREVENTS INVASIVE BREAST CANCER IN POSTMENOPAUSAL WOMEN
    不详
    CANCER DISCOVERY, 2011, 1 (02) : 96 - 96
  • [26] High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment
    Kvinnsland, S
    Anker, G
    Dirix, LY
    Bonneterre, J
    Prove, AM
    Wilking, N
    Lobelle, JP
    Mariani, O
    di Salle, E
    Polli, A
    Massimini, G
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (08) : 976 - 982
  • [27] Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
    J. G. H. van Nes
    D. B. Y. Fontein
    E. T. M. Hille
    D. W. Voskuil
    F. E. van Leeuwen
    J. C. J. M. de Haes
    H. Putter
    C. Seynaeve
    J. W. R. Nortier
    C. J. H. van de Velde
    Breast Cancer Research and Treatment, 2012, 134 : 267 - 276
  • [28] Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
    van Nes, J. G. H.
    Fontein, D. B. Y.
    Hille, E. T. M.
    Voskuil, D. W.
    van Leeuwen, F. E.
    de Haes, J. C. J. M.
    Putter, H.
    Seynaeve, C.
    Nortier, J. W. R.
    van de Velde, C. J. H.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 267 - 276
  • [29] Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients
    Carlini, Paolo
    Michelotti, Andrea
    Ferretti, Gianluigi
    Ricci, Sergio
    Giannarelli, Diana
    Biostatistic, Diana Giannarelli
    Pellegrini, Manuela
    Cresti, Nicola
    Di Cosimo, Serena
    Bria, Emilio
    Papaldo, Paola
    Fabi, Alessandra
    Ruggeri, Enzo Maria
    Milella, Michele
    Alimonti, Andrea
    Salesi, Nello
    Cognetti, Francesco
    CANCER INVESTIGATION, 2007, 25 (02) : 102 - 105
  • [30] Systemic therapy of metastatic breast cancer in postmenopausal patients
    Rose, C
    Lornan, N
    Killander, F
    Kinhult, S
    ADVANCES IN ENDOCRINE THERAPY OF BREAST CANCER, PROCEEDINGS, 2004, : 33 - 46
12345